𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The epidermal growth factor receptor and the prognosis of bladder cancer

✍ Scribed by David E. Neal; Linda Sharples; Kenneth Smith; Janet Fennelly; Reg R. Hall; Adrian L. Harris

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
634 KB
Volume
65
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of epidermal growth factor re
Expression of epidermal growth factor receptor in urinary bladder cancer metastases
✍ Peter Bue; Kenneth Wester; Anna Sjöström; Anders Holmberg; Sten Nilsson; Jörgen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 518 KB

Bladder cancers frequently exhibit an increased number of epidermal growth factor receptors (EGFR) in comparison to normal urothelium. The EGFR could potentially be a target for toxic conjugates. The aim of our study was to compare the expression of EGFR in metastases with concurrent or primary tumo

Detection of circulating cancer cells ex
Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients
✍ Iman Osman; Melissa Kang; Andy Lee; Fang-Ming Deng; David Polsky; Maryann Mikhai 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB 👁 1 views

## Abstract Our purpose was to determine the clinical relevance of the detection of circulating tumor cells (CTCs) expressing urothelial and epithelial markers in bladder cancer patients. Sixty‐two patients who presented to Memorial Sloan‐Kettering Cancer Center between July 2000 and September 2001

Heparin-binding epidermal growth factor-
Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome
✍ Christopher Kramer; Kai Klasmeyer; Hans Bojar; Wolfgang A. Schulz; Rolf Ackerman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

## Abstract ## BACKGROUND. Cleavage of membrane‐anchored heparin‐binding epidermal growth factor‐like growth factor (proHB‐EGF) yields a soluble HB‐EGF isoform (sHB‐EGF), which is an activating epidermal growth factor receptor (EGFR) ligand and a C‐terminal fragment HB‐EGF‐C acting directly in the